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Abstract Cancer, a chronic disease has become one of the primary causes 
of death in advanced countries. The diagnosis, medication and treatment 
for cancer is very expensive. Healthcare providers, especially in cancer 
care, need to automate and accelerate access to patient data and evidence 
based decision making along with greater quality control and safety. 
Oncology information systems (OIS) provide a simple solution for this. 
This study compared 3 different leading international oncology information 
systems capable of delivering high-value, patient centred care to cancer 
patients in the Australian context. This work analysed functionality, 
usability and interoperability of these systems for the Australian healthcare 
environment and their integration with existing systems and assets. Critical 
success factors in the design of platforms to make them perform better from 
clinicians’ and patients’ points of view have also been discussed.  
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1 Introduction 
 
Along with other chronic diseases, cancer has become one of the leading causes of death 
("Cancer in Australia," 2017; Torre, Siegel, Ward, & Jemal, 2016; Yach, Hawkes, Gould, 
& Hofman, 2004). By the age of 85, one in two Australians will be diagnosed with cancer 
and 1 in 5 will die from cancer ("Twitter graphic cancer in Aust 2017,"). Males (around 
54%) are more likely to suffer from cancer than females (around 46%). 1 in 3 males 
whereas 1 in 4 females will be identified with cancer by the age of 75 ("Cancer in 
Australia 2017," 2017). As shown in Table 1, it was estimated that in 2017 around 
134,174 people will be identified as cancer sufferers and that the number of cancer cases 
is expected to rise further to 150,000 till 2020. Cancer related treatments and medicines 
are extremely expensive; in Australia, the health care system bears most of the burden 
which is more than $4.5 billion (6.9%) ("Cancer in Australia," 2017). Typical, treatment 
protocols of cancer patients involve surgery, radiation therapies and chemotherapy 
(Crawford, 2013). These procedures involve critical control over surgery, the amount of 
radiation and cytotoxic doses for chemotherapy (Wickramasinghe, Haddad, Vaughan, 
Han-Lin, & Moghimi, 2015). 
 
Table 1: Estimated incidence of all cancers combined, by sex, 2017 ("Cancer in Australia 
2017," 2017) 
 Males Females Persons 
Number of cases 72,169 62,005 134,174 
Age-standardised rate 525.9 422.9 469.6 
Per cent of all cancer 
cases 
53.8 46.2 100.0 
Risk to age 75 1 in 3 1 in 4 1 in 3 
Risk to age 85 1 in 2 1 in 2 1 in 2 
 
In general, people living in Australia have a better chance of survival than people living 
in other parts of the world ("Cancer in Australia 2017," 2017; "Cancer in Australia in 
breif 2017," 2018; "Twitter graphic cancer in Aust 2017,"). This is attributed to better 
awareness and improved clinical care (Crawford, 2013). The overall reduction in cancer 
incidences, in Australia is primarily due to decreased number of cases in prostate cancer 
in men ("Prostate cancer in Australia," 2013). This decline in cancer trends could be 
associated to increased awareness and prostate specific antigen (PSA) testing in males 
("Cancer in Australia in breif 2017," 2018). 
 
2 Need for OIS (oncology information system) 
 
Owing to new advancements in diagnostic and treatment therapies, today we are in a 
better position to identify early and understand more fully diseases and their management, 
resulting in longer and healthier life outcomes ("Cancer in Australia 2017," 2017). This 
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era of knowledge and easy access to information through the Internet, print and electronic  
media has made us more demanding of every aspect of health and wellbeing (Duckett & 
Willcox, 2015). It is a well-established fact that improved health literacy leads to better 
health outcomes (Nutbeam, 2008). Overall, it has put an enormous burden over global 
healthcare systems due to an ageing population (Prince et al., 2015; Yach et al., 2004). In 
such a challenging situation, even a small error in treatment, documentation or missing a 
scheduled appointment can be fatal and can cost a huge amount to the healthcare system 
(Berwick, 2003).  To cope with these errors and get up to date information about patient 
history, medication and treatments, electronic health records and data systems have been 
introduced in many advanced countries (Sulaiman & Wickramasinghe, 2014; 
Wickramasinghe & Schaffer, 2010). These electronic healthcare records (EHR) can help 
in managing a single record instead of multiple records for same patient, and thus also 
reducing multiple testing/treatment or medication (Duncan et al., 2010; Hillestad et al., 
2005).  
 
Especially, when it comes to treating of cancer patients, the need to avoid every possible 
error becomes even more crucial due to the toxicity and cost of drugs and radiation 
therapies (Evans, Ashbury, Hogue, Smith, & Pun, 2014; Fasola et al., 2008). Therefore, 
the need to synchronize all treatments, provide instant access to updated records and 
information on the latest state of tumour/disease and informed decision making through 
a cancer registry becomes very crucial (Duncan et al., 2010). No two cancer patients are 
the same, even though there might be two persons having similar conditions and 
symptoms of cancer, their treatment plan and recovery will vary depending upon a variety 
of different factors (Štambuk, Šundov, Kuret, Beljan, & Anđelinović, 2010; 
"Understanding Cancer," 2018). Therefore, their treatment needs to be very personal and 
entirely customised to help them recover better and faster ("No two breast cancer patients 
are the same and treatment should be tailored ", 2018). Thus, arising a necessity for 
incorporating a variety of treatment plans and multidisciplinary departments within or 
across the hospitals into one single system (Crawford, 2013; Herre & Heller, 2004).  
 
The utilization of an oncology information system (OIS) helps in integration of radiation 
oncology, particle therapy and medical oncology patient data into a single database with 
multi-user and multiple site access (Janssen et al., 2017). The OIS seamlessly connects to 
any linear accelerator and treatment planning system. It also helps in the evaluation and 
comparison of patients under treatment to existing data in cancer registries, using artificial 
intelligence (A.I.) to speed up process and minimize errors. Development of disease 
specific clinical protocols are made easy by OIS and it helps in generating standard and 
consistent care (Krayenbuehl, Norton, Studer, & Guckenberger, 2015). By utilizing OIS, 
clinicians can monitor the amount of dose and review treatment images in one single 
system to determine if they need to change the dosing plan (Cheng, Wu, Liu, & Kwong, 
2011). 
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3 Methodology 
 
The objective of this exploratory qualitative study was to assess the critical aspects of 
leading OIS when implemented into the Australian healthcare context. To do this, we 
adopted a mixed methodology; first we compared 3 leading solutions that were developed 
either in US or Europe. Comparisons were made by performing a hermeneutic analysis 
on all publically available data. In addition, site visits (public and private healthcare 
sector) took place. We then conducted focus group discussion respectively with patients 
and clinicians (in both the public and private sectors) to further ascertain their 
perspectives of features they would like in such systems and how these might be 
beneficial. The initial findings are presented below. 
 
3.1 Comparison and discussion of different OIS: 
 
Three different leading international oncology information systems were analysed. 
Specifically, their main features as relevant and beneficial in the Australian health care 
system for cancer care were examined. The summary of the comparison is presented in 
Table 2. After completing the comparison for these systems, a focus group discussion 
with oncology clinicians & patients was conducted to further gain important insights.  
 
From Clinician and healthcare provider’s point of view it was noted that most of the 
providers (public hospitals and private) have had different systems of patient data 
recording and maintaining. This makes it challenging for clinicians who must work with 
multiple systems. Different hospitals are now collaborating, or amalgamating to become 
a big single healthcare provider through acquisitions. This then means that they need to 
integrate their previously separate systems within and across the different sites. This is 
challenging however, due to the differences of existing infrastructure and their versions; 
hence, more often than not poor integration, disrupted work flow and different user 
interfaces result. After discussions with oncology clinicians and managers at different 
healthcare organisations, critical factors were identified to improve the overall 
performance of OIS including:  
 Adherence to agreed international and Australian standards 
 Interoperability and leverage of existing assets and capabilities 
 Need to fit Australian/Victorian healthcare system e.g., VMOs (visiting medical 
officers) 
 Inclusion of billing and concession through PBS and MBS systems  
 Need for real time data exploring, updating and communication of change in 
plan 
 Special attention to encryption, privacy and cyber security issues 
 Need for auto triggering and notification of change in plan for medication or 
radiation  
 Need to distribute and calculate share for specialists and nurses 
 Licensing issues within and among different health care providers 
 Transferring and accessing data within and from different sites  
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 Access for organizations not having OIS e.g., Medicare or other agencies 
 Consistency around treatments protocols, timelines and costing forecasting  
 Web based with login access from anywhere  
 Value for money, the selected digital technology must be cost effective and 
productive 
 OIS must be capable for keeping track of safety and quality control in 
medication, treatment, scheduling of appointments. 
 
From patient, family members and care provider’s points of view, it was found that the 
person who suffers the most is the cancer patient and family members. The patient and 
family members’ needs and desires tend to be the most ignored during the treatment and 
recovery phases and hence the patient experience is less than satisfactory. For many 
clinicians, nurses and healthcare providers the patient is just another subject and one more 
case study for different treatments. The patients were desirous of more empowerment and 
access to information and data through psychological surveys, awareness / training, visual 
treatment, booking/cancelling/ rescheduling their appointments. Further, having the 
capacity to participate in patient reported outcomes and self-reporting pain and progress 
of recovery on a daily and hourly basis was key for them to improve their patient 
experience. Many patients also wanted the ability to log their medication e.g., missing 
and on-time or ordering for repeats. To summarise, the key factors from Australian patient 
point of view: 
 Pain grading and registering  
 User friendly interface and ease of interpretation 
 Psychological, emotional and social support or stories  
 Up to date knowledge on new treatments and ongoing research 
 Training and visual experiences for treatments and therapies 
 Automatic concession and payments through PBS and MBS 
 Keeping privacy and confidentiality of patients, the data should be available 
anonymously for research and matching with similar case studies, their 
implications, complications and recoveries.  
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Table 3: Comparison of different leading international oncology inforamtion systems (OIS) 
in Australian context  
 
 System A System B System C 
Multiple 
therapies 
(medical &  
radiation 
oncology) 
• Yes • Yes • Yes 
Billing 
 
• Billing & cancer registry  
• Missed-procedure billing 
advisories 
• Export billed items to HL7-
compliant billing software 
• Billing and 
other third-party 
systems  
• Claims and 
billing data 
from 
financial 
systems 
Image 
management 
• Comprehensive review of 
clinical images 
• Optimized image-guided 
treatment techniques  
• Review images remotely and 
send set-up instructions to the 
treatment machine 
• Review dosimetric images for 
IMRT pre-treatment quality 
assurance 
• Compare images using 
automatic, manual or fiducial 
marker-matching algorithms 
• Attach images, files or patient 
photographs to documents 
• Sophisticated 
image 
visualization & 
distribution 
• 3D viewers: 
RTP, XVI, & 
iView GT™ 
integration, 
adding and 
synchronizing 
tools, 2D image 
registration, 
volume image 
viewing 
• External image 
registration 
• Stereoscopic & 
volume  image 
registration 
• Setup details, 
immobilization 
devices and 
reference 
images entered 
into treatment 
chart 
• Present 
complex, 
personalized 
analytics on 
individual 
patients 
based on 
clinical, 
molecular, 
and other 
relevant data 
in a clinically 
actionable 
format 
Clinician led and 
patient-centric  
• Appointment scheduling, review 
images remotely, customisable data 
collection forms and questionnaires 
• Electronic patient 
management allows 
users to achieve a 
paperless, filmless 
working 
environment; 
treatment setup 
Configure CARE 
reports to contain 
personalized 
analytic content 
and historical 
patient content 
formatted to your 
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workflow 
management 
institution’s & 
clinician’s specific 
needs 
Information and 
analytics  
Pain scoring to identify trends Trend analysis 
Integration, 
aggregation & 
personalized 
analytics on highly 
complex, 
disparate, multi-
institutional data 
sources 
Adherence to 
agreed standards 
and 
interoperability 
& leveraging 
existing assets 
and capabilities  
• Automates patient-data transfer 
with external hospital systems using 
standard communication protocols 
• Seamless 
connectivity to 
virtually any linear 
accelerator &  
treatment planning 
system from any 
vendor, providing 
unmatched 
integration, freedom 
and flexibility 
IT team, data and 
network security 
resulting in very 
fast time-to-value. 
PBS / MBS - - - 
Robust privacy, 
security and data 
protection 
• Built-in EDI (electronic data 
interchange) for 
secure online claim submissions 
• High Availability and Rapid 
Recovery Protection (HARRP) 
continuous data protection and 
ensures minimal data loss and 
immediate recovery 
• Eliminate error-prone 
work through tight 
integration that 
enables the seamless 
transition of data 
between tools 
- 
Safety and 
Quality 
Facilitates compliance with the 
Work Health and Safety (WHS) 
Act   
• Manual, barcode and 
biometric patient 
identification and 
verification options 
provide multilevel 
safety checkpoints 
Quality and safety 
reporting. 
Comparison of 
cost, 
complications, 
toxicity and 
practice 
- - 
System C gives 
comparison of 
cost, 
complications, 
toxicity and even 
between different 
practice centres or 
clinics. 
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4 Conclusion  
 
This study is a first step in a longer research stream to identify key needs and critical 
success factors for OISs. We conducted a comparison of 3 leading international OISs and 
followed this up by focus group discussions with clinicians and patients (both public and 
private healthcare sectors) respectively. Our initial findings have been summarized above. 
Cancer is becoming a leading cause of death globally and has stretched healthcare budgets 
due to expensive medicine and radiation therapies. Oncology information systems can 
help in integrating patient history, imaging data, medication, radiation, recovery & 
progress and change in plan from multiple users and multiple sites. Unfortunately, most 
of the leading international OIS available are not designed and customized for the 
Australian context. Communication and interoperability among existing systems and 
assets along with access to medical specialists and government agencies for up to date 
data monitoring and subsidized treatments need to be included into these systems. From 
patient’s prospective, ease and access of using systems for appointment scheduling, 
rescheduling and cancelling, learning regarding treatment protocols and pathways 
available, survivor stories, peer and family support, pain grading & registering and finally 
medication missing or overdosing logging were main concerns. Inclusion of these key 
factors into any oncology information systems will make such system more likely to gain 
strong clinician and patient user satisfaction and thereby provide a successful and superior 
transformation of care in this context. 
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